Australian study shows that end-stage renal disease develops in 1.7% of patients with 3 years of undergoing nephrectomy for kidney cancer.
Study of patients with clinical T1a renal cell carcinoma shows that those who undergo renal mass biopsy have only a 1.2% rate of upstaging to pT3a perinephric fat involvement.
Propensity score-matched analysis shows that radical and partial nephrectomy for cT1 renal cell carcinoma are associated with similar cancer-specific and all-cause mortality, a study found.
Older age, male sex, and higher T stage are associated with an increased risk of having bone metastases at initial diagnosis of renal cell carcinoma, study finds.
Partial vs radical nephrectomy is associated with an overall survival advantage among patients with RCC tumors 4 cm or smaller and many patients with larger tumors.
A neutrophil-lymphocyte ratio below 4 is associated with significantly longer survival among patients with non-poor-risk metastatic renal cell carcinoma.
Finnish study of individuals with type 2 diabetes reveals a 17% and 42% higher incidence of bladder and kidney cancer, respectively, compared with the general population.
In a German study of patients starting first-line systemic therapy for advanced renal cell carcinoma, patients with a low BMI were twice as likely to die as those with a high BMI.
Prospective study at Johns Hopkins shows excellent oncologic outcomes and preserved mental quality of life for all patients regardless of management strategy, with worse renal function after radical nephrectomy.
Nonsurgical treatment of small tumor renal cancer may be as effective as radical nephrectomy but with fewer complicationsAugust 23, 2018
1. Rates of renal insufficiency were highest in patients receiving renal nephrectomy, compared to less invasive treatments. 2. Survival rates for renal nephrectomy and partial nephrectomy were very similar, suggesting little difference in efficacy between these treatments. Evidence Rating Level: 2 (Good) Study Rundown: Renal stage carcinoma (RCC) has relatively low mortality rates with respect 
A "weekday-on and weekend-off regimen" improves relative dose intensity compared with the conventional regimen, a study found.
In a study, the off-clamp approach to partial nephrectomy also was associated with lower risk for acute kidney injury.
Circulating blood biomarkers related to angiogenesis may help clinicians predict who will have a robust response to sunitinib.
Obesity is associated with an increased likelihood of clear cell and possibly chromophobe renal cell carcinoma.
The likelihood of aggressive kidney tumor histology increased along with tumor size, a new study found.
Over a 25-year period, the proportion of patients with high-risk clinical T1 tumors increased by nearly 20% and clinical tumor size decreased from 8.4 to 6.2 cm, an Italian study found.
Robotic PN was associated with significantly lower rates of complications, cancer recurrence, and mortality compared with open and laparoscopic PN.
The association between obesity, age, and renal cell carcinoma prognosis requires additional investigation.
Percutaneous ablation offers cancer-related outcomes similar to those of radical nephrectomy but with a lower likelihood of long-term renal insufficiency and complications.
Increased risk of subsequent diabetes independent of traditional diabetes risk factors.
In 2015, 69% of surgeries for prostate, bladder, and kidney cancer were performed with robotic assistance, a new meta-analysis shows.
New findings from the CARMENA trial contradict previous research showing better survival from cytoreductive nephrectomy followed by targeted therapy.
Race, procedure and insurance type, sex, surgeon volume, and hospital size influence the risk of readmission among patients undergoing radical nephrectomy, study finds.
Study shows that partial nephrectomy for small renal tumors is associated with lower risk of cancer-specific and other-cause mortality in patients aged 75 years and older.
Men and women who smoke are at 2.3-fold and 2.7-fold increased risk of bladder cancer compared with non-smokers.
Doctors who receive general payment for cancer drug more likely to prescribe drug marketed by company.
1. Amongst patients with advanced renal-cell carcinoma and an intermediate or poor prognosis, nivolumab plus ipilimumab was superior to sunitinib alone in improving overall survival. 2. Though not statistically compared, there was a lower incidence of grade three or four adverse events with nivolumab plus ipilimumab, although more patients in the combination therapy arm stopped 
An evaluation of patients with clear cell renal cell carcinoma revealed greater risk of death for female patients with high relative visceral fat area (rVFA), highlighting the significance of metabolic differences between men and women.
Myocarditis with ICIs may be more common than initially thought; responds to higher steroid dosages
The risk of dying from pT1a renal cell carcinoma after partial or radical nephrectomy increases along with patient age.
Renal and Urology News Articles
- Genetic Differences in Prostate Cancer Pinpointed in Black Men
- Clinical Gout-Related Benefits Not Seen With Lesinurad Combo Tx
- High Variability in Metabolic Measures May Up Mortality
- Sitagliptin Better for Glycemic Control in T2D With Renal Impairment
- Ultrasound Can Reveal Renal Medulla Urate Deposits in Tophaceous Gout
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)